Jeffrey Molldrem

2001 grant recipient Jeffrey Molldrem, MD of MD Anderson Cancer Center in Texas identifies a vaccine that, for the first time ever, produces complete responses in a clinical trial for patients with advanced myeloid leukemia for whom no other therapy had been successful.